Document Detail


Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome.
MedLine Citation:
PMID:  14730325     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We examined circadian blood pressure (BP) variation (expressed as a relative night-time BP decline) in subjects with primary aldosteronism (78 patients), pheochromocytoma (n=45) and Cushing's syndrome (n=18). Subjects with aldosterone-producing adenoma (n=21) and pheochromocytoma (n=27) were also investigated after the tumour removal. In all, 65 patients with essential hypertension served as a control group. The night-time BP decline was significantly attenuated in all three forms of endocrine hypertension compared to the control group (primary aldosteronism P<0.0001, pheochromocytoma P<0.0001 for systolic and diastolic BP and Cushing's syndrome P<0.0001/<0.001 vs essential hypertension). In the case of pheochromocytoma, the absence of the night-time BP decrease was more prominent compared to the primary aldosteronism group (P=0.003/0.001) and for the diastolic BP also in comparison with the Cushing's syndrome group (P=0.03). Tumour removal led in both groups to the restoration of the previously altered circadian rhythm (aldosterone-producing adenoma: P=0.0005/0.0009; pheochromocytoma: P=0.001/0.0007). Our study demonstrates a blunted circadian BP variation in all forms of adrenal hypertension in comparison with essential hypertension. This reduction of the night-time BP decrease was more prominent in pheochromocytoma than in primary aldosteronism or Cushing's syndrome.
Authors:
T Zelinka; B Strauch; L Pecen; J Widimský
Related Documents :
19812355 - The role of aldosterone in mediating the dependence of angiotensin hypertension on il-6.
15229305 - Serum aldosterone and the incidence of hypertension in nonhypertensive persons.
17884095 - A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic ...
1560165 - Hypertension during reduction of long-term steroid therapy in young subjects with asthma.
3465915 - Role of vascular structure in blood pressure development of the spontaneously hypertens...
8820475 - Fish oil as an adjuvant in the treatment of hypertension.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of human hypertension     Volume:  18     ISSN:  0950-9240     ISO Abbreviation:  J Hum Hypertens     Publication Date:  2004 Feb 
Date Detail:
Created Date:  2004-01-19     Completed Date:  2004-05-13     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8811625     Medline TA:  J Hum Hypertens     Country:  England    
Other Details:
Languages:  eng     Pagination:  107-11     Citation Subset:  IM    
Affiliation:
3rd Department of Medicine, First Faculty of Medicine, Charles University, General Faculty Hospital, Prague, Czech Republic. tzeli@lf1.cuni.cz
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenal Gland Neoplasms / physiopathology*,  surgery
Adult
Aged
Aldosterone / biosynthesis
Blood Pressure*
Blood Pressure Determination
Case-Control Studies
Circadian Rhythm
Cushing Syndrome / physiopathology*
Female
Humans
Hyperaldosteronism / physiopathology*,  surgery
Hypertension / physiopathology*
Male
Middle Aged
Pheochromocytoma / physiopathology*,  surgery
Chemical
Reg. No./Substance:
52-39-1/Aldosterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Impact of the high-risk and mass strategies on hypertension control and stroke mortality in primary ...
Next Document:  Secular decrease in blood pressure and reduction in mortality from cardiovascular disease in Israeli...